Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (33 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | ICICI Prudential MidCap Fund |
|---|---|
| 02 Apr 2006 | ₹100.00 |
| 13 Dec 2007 | ₹120.35 |
| 25 Aug 2009 | ₹56.63 |
| 07 May 2011 | ₹66.47 |
| 17 Jan 2013 | ₹72.80 |
| 29 Sep 2014 | ₹103.21 |
| 11 Jun 2016 | ₹93.67 |
| 21 Feb 2018 | ₹112.96 |
| 03 Nov 2019 | ₹96.37 |
| 16 Jul 2021 | ₹128.25 |
| 28 Mar 2023 | ₹109.04 |
| 08 Dec 2024 | ₹175.38 |
| 20 Aug 2026 | ₹190.41 |
| Metric | ICICI Prudential · Regular · IDCW NAV ₹45.09 Very High risk ★☆☆☆☆ | Category median Mid Cap Fund · 33 funds |
|---|---|---|
| +6.32% | +4.36% | |
| +13.22% | +14.16% | |
| +8.78% | +13.38% | |
| +6.17% | +7.79% | |
| +3.21% | +9.71% | |
| +11.01% | — | |
| +5.61% | +11.96% | |
| +5.42% | +10.86% | |
| +5.16% | +9.43% | |
| Risk | ||
| 19.54% | 17.59% | |
| 0.34 | 0.44 | |
| 0.44 | 0.61 | |
| -79.21% | -47.34% | |
| Nifty Midcap 150 | — | |
| -3.21% | -3.13% | |
| 0.93 | 0.97 | |
| 79.3% | 91.4% | |
| 85.1% | 102.1% | |
| 1.84% | 2.04% | |
| ₹7,594Cr | ₹9,315Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹5.00K | — | |
| 75% | 41% | |
| Lalit Kumar | — | |
| 02 Apr 2006 | — | |
| 80 | — | |
| 38.0% | — | |
| 2.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.